Osteoporosis natural history, complications and prognosis: Difference between revisions
Tarek Nafee (talk | contribs) |
|||
(6 intermediate revisions by 2 users not shown) | |||
Line 9: | Line 9: | ||
=== Natural history === | === Natural history === | ||
*Symptoms of [[osteoporosis]] typically develop in the sixth decade of life. The risk of [[osteoporosis]] increases proportionately with age | *Symptoms of [[osteoporosis]] typically develop in the sixth decade of life. | ||
*The risk of [[osteoporosis]] increases proportionately with age.<ref name="pmid9797914">{{cite journal |vauthors=Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, Dudley EC, Burger HG, Wark JD |title=A prospective study of bone loss in menopausal Australian-born women |journal=Osteoporos Int |volume=8 |issue=3 |pages=282–90 |year=1998 |pmid=9797914 |doi=10.1007/s001980050066 |url=}}</ref> | |||
*Another major factor that directly affects [[Bone mineral density|BMD]] is [[body weight]]. Women with increased body weight and [[Body mass index|body mass index (BMI)]] have more changes in their [[Bone mineral density|BMD]] in both [[hip]] and [[lumbar spine]] as they age. | |||
*Another major factor that directly | *[[Bone]] site is an important factor to determine the measure of [[bone]] loss. The magnitude of [[bone density]] loss is higher at the spine (-3.12% annually) compared to the [[femoral neck]] (1.67% annually). The main proposed theory for the phenomenon is "different effect of [[estrogen]] deficiency on different [[bone]] sites". | ||
* | |||
* With the appropriate and timely usage of [[medications]] along with [[calcium]] and/or [[vitamin D]] supplementation, the outcome of [[osteoporosis]] is usually good. But if the disease is left untreated, or not treated optimally, results in [[Fractures|fracture]] leading to increased morbidity and mortality. | * With the appropriate and timely usage of [[medications]] along with [[calcium]] and/or [[vitamin D]] supplementation, the outcome of [[osteoporosis]] is usually good. But if the disease is left untreated, or not treated optimally, osteoporosis results in [[Fractures|fracture]] leading to increased morbidity and mortality. | ||
* [[Vertebral]] [[fracture|fractures]] are more common and affect the quality of life more significantly.<ref name="pmid9102060">{{cite journal |vauthors=Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Liberman U, Minne H, Reeve J, Reginster JY, de Vernejoul MC, Wiklund I |title=Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis |journal=Osteoporos Int |volume=7 |issue=1 |pages=36–8 |year=1997 |pmid=9102060 |doi= |url=}}</ref> | |||
===Complications=== | ===Complications=== | ||
The major complications of [[osteoporosis]] include: | |||
* [[Fractures]]: [[hip]] and [[lumbar]] spine are among the most frequent sites of [[fracture]]. | |||
* [[DVT|Deep venous thrombosis (DVT)]]: It can be caused by prolonged [[immobility]]. | |||
* [[Kyphosis]] (Dowager's hump): Due to decreased height of anterior aspect of [[cervical]] [[vertebrae]] body (wedge shape). | |||
* [[Restrictive lung disease]]: Due to decreased [[thoracic]] space, due to [[vertebrae|vertebral]] compression. | |||
* Apart from the risk of death and other complications, osteoporotic [[Bone fracture|fractures]] are associated with a reduced [[quality of life]] due to [[immobility]] and other emotional problems resulting from osteoporosis.<ref>{{cite journal |author=Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES |title=Impact of recent fracture on health-related quality of life in postmenopausal women |journal=J. Bone Miner. Res. |volume=21 |issue=6 |pages=809–16 |year=2006 |pmid=16753011 |doi=10.1359/jbmr.060301}}</ref> | * Apart from the risk of death and other complications, osteoporotic [[Bone fracture|fractures]] are associated with a reduced [[quality of life]] due to [[immobility]] and other emotional problems resulting from osteoporosis.<ref>{{cite journal |author=Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES |title=Impact of recent fracture on health-related quality of life in postmenopausal women |journal=J. Bone Miner. Res. |volume=21 |issue=6 |pages=809–16 |year=2006 |pmid=16753011 |doi=10.1359/jbmr.060301}}</ref> | ||
Line 63: | Line 64: | ||
===Prognosis=== | ===Prognosis=== | ||
* Early identification of the [[Bone mineral density|bone mass density]] loss and appropriate treatment results in a good prognosis of osteoporosis. | * Early identification of the [[Bone mineral density|bone mass density]] loss and appropriate treatment results in a good prognosis of osteoporosis. | ||
* | * Osteoporotic fractures are increased by: | ||
**Advancing age | **Advancing age | ||
**Low [[Bone mineral density|BMD]] | **Low [[Bone mineral density|BMD]] | ||
* | * The lifetime [[Bone fracture|fracture]] at age 60 adjusted with the death rate may be as high as 44% for women and 25% for men. | ||
* The lifetime [[fracture]] risk for [[hip]] is 9% in women and 4% in men. | |||
* Similarly, [[fracture]] risk of [[hip]] and [[vertebrae]] in men (15%) is totally noticeable along with their [[prostate cancer]] risk. | |||
* Most children with [[idiopathic]] juvenile [[osteoporosis]] (IJO) experience a complete recovery of [[bone]] tissue. Although growth may be somewhat impaired during the acute phase of the disorder, normal growth resumes and catch-up growth often occurs afterwards. | |||
* In some cases, IJO can result in permanent disability such as [[kyphoscoliosis]] or collapse of the [[rib cage]].<ref name="urlJuvenile Osteoporosis">{{cite web |url=https://www.niams.nih.gov/health_info/bone/Bone_Health/Juvenile/juvenile_osteoporosis.asp |title=Juvenile Osteoporosis |format= |work= |accessdate=}}</ref> | |||
==Monitoring== | |||
Suggested follow-up:<ref name="pmid22256806">{{cite journal| author=Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui LY | display-authors=etal| title=Bone-density testing interval and transition to osteoporosis in older women. | journal=N Engl J Med | year= 2012 | volume= 366 | issue= 3 | pages= 225-33 | pmid=22256806 | doi=10.1056/NEJMoa1107142 | pmc=3285114 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22256806 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=22782920 Review in: Evid Based Med. 2013 Feb;18(1):e7] [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=23000664 Review in: J Fam Pract. 2012 Sep;61(9):555-6] </ref> | |||
* Normal (T score, −1.00 or higher)- 15 years | |||
* Mild osteopenia (T score, −1.01 to −1.49) - 15 years | |||
* Moderate osteopenia (T score, −1.50 to −1.99) - 5 years | |||
* Advanced osteopenia (T score, -2.00 to −2.49) - 1 year | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| |||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date | [[Category:Up-To-Date]] | ||
Latest revision as of 14:57, 1 June 2023
Osteoporosis Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Osteoporosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Osteoporosis natural history, complications and prognosis |
FDA on Osteoporosis natural history, complications and prognosis |
CDC on Osteoporosis natural history, complications and prognosis |
Osteoporosis natural history, complications and prognosis in the news |
Blogs on Osteoporosis natural history, complications and prognosis |
Risk calculators and risk factors for Osteoporosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Overview
If left untreated, most of the patients with osteoporosis develop fractures. With the appropriate and timely usage of medications along with calcium and/or vitamin D supplementation, the outcome of osteoporosis is usually good. Apart from the risk of death and other complications, osteoporotic fractures are associated with deep venous thrombosis, kyphosis, and a reduced quality of life due to immobility.
Natural History, Complications, and Prognosis
Natural history
- Symptoms of osteoporosis typically develop in the sixth decade of life.
- The risk of osteoporosis increases proportionately with age.[1]
- Another major factor that directly affects BMD is body weight. Women with increased body weight and body mass index (BMI) have more changes in their BMD in both hip and lumbar spine as they age.
- Bone site is an important factor to determine the measure of bone loss. The magnitude of bone density loss is higher at the spine (-3.12% annually) compared to the femoral neck (1.67% annually). The main proposed theory for the phenomenon is "different effect of estrogen deficiency on different bone sites".
- With the appropriate and timely usage of medications along with calcium and/or vitamin D supplementation, the outcome of osteoporosis is usually good. But if the disease is left untreated, or not treated optimally, osteoporosis results in fracture leading to increased morbidity and mortality.
- Vertebral fractures are more common and affect the quality of life more significantly.[2]
Complications
The major complications of osteoporosis include:
- Fractures: hip and lumbar spine are among the most frequent sites of fracture.
- Deep venous thrombosis (DVT): It can be caused by prolonged immobility.
- Kyphosis (Dowager's hump): Due to decreased height of anterior aspect of cervical vertebrae body (wedge shape).
- Restrictive lung disease: Due to decreased thoracic space, due to vertebral compression.
- Apart from the risk of death and other complications, osteoporotic fractures are associated with a reduced quality of life due to immobility and other emotional problems resulting from osteoporosis.[3]
Fracture risk
Fracture risk categories in glucocorticoid-treated patients are listed in the table below.[4]
Adults ≥ 40 years of age | Adults <40 years of age | |
---|---|---|
High fracture risk |
|
|
Moderate fracture risk |
|
or and
|
Low fracture risk |
|
|
Prognosis
- Early identification of the bone mass density loss and appropriate treatment results in a good prognosis of osteoporosis.
- Osteoporotic fractures are increased by:
- Advancing age
- Low BMD
- The lifetime fracture at age 60 adjusted with the death rate may be as high as 44% for women and 25% for men.
- The lifetime fracture risk for hip is 9% in women and 4% in men.
- Similarly, fracture risk of hip and vertebrae in men (15%) is totally noticeable along with their prostate cancer risk.
- Most children with idiopathic juvenile osteoporosis (IJO) experience a complete recovery of bone tissue. Although growth may be somewhat impaired during the acute phase of the disorder, normal growth resumes and catch-up growth often occurs afterwards.
- In some cases, IJO can result in permanent disability such as kyphoscoliosis or collapse of the rib cage.[5]
Monitoring
Suggested follow-up:[6]
- Normal (T score, −1.00 or higher)- 15 years
- Mild osteopenia (T score, −1.01 to −1.49) - 15 years
- Moderate osteopenia (T score, −1.50 to −1.99) - 5 years
- Advanced osteopenia (T score, -2.00 to −2.49) - 1 year
References
- ↑ Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, Dudley EC, Burger HG, Wark JD (1998). "A prospective study of bone loss in menopausal Australian-born women". Osteoporos Int. 8 (3): 282–90. doi:10.1007/s001980050066. PMID 9797914.
- ↑ Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Liberman U, Minne H, Reeve J, Reginster JY, de Vernejoul MC, Wiklund I (1997). "Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis". Osteoporos Int. 7 (1): 36–8. PMID 9102060.
- ↑ Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006). "Impact of recent fracture on health-related quality of life in postmenopausal women". J. Bone Miner. Res. 21 (6): 809–16. doi:10.1359/jbmr.060301. PMID 16753011.
- ↑ Buckley, Lenore; Guyatt, Gordon; Fink, Howard A.; Cannon, Michael; Grossman, Jennifer; Hansen, Karen E.; Humphrey, Mary Beth; Lane, Nancy E.; Magrey, Marina; Miller, Marc; Morrison, Lake; Rao, Madhumathi; Robinson, Angela Byun; Saha, Sumona; Wolver, Susan; Bannuru, Raveendhara R.; Vaysbrot, Elizaveta; Osani, Mikala; Turgunbaev, Marat; Miller, Amy S.; McAlindon, Timothy (2017). "2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis". Arthritis & Rheumatology. 69 (8): 1521–1537. doi:10.1002/art.40137. ISSN 2326-5191.
- ↑ "Juvenile Osteoporosis".
- ↑ Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui LY; et al. (2012). "Bone-density testing interval and transition to osteoporosis in older women". N Engl J Med. 366 (3): 225–33. doi:10.1056/NEJMoa1107142. PMC 3285114. PMID 22256806. Review in: Evid Based Med. 2013 Feb;18(1):e7 Review in: J Fam Pract. 2012 Sep;61(9):555-6